Drugs / Tazobactem
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00478855 | Sep 2006 → Jun 2007 | bacterial infectious disease | Wyeth is now a wholly owned subsidiary of Pfizer | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tazobactem | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00478855 ↗ |